Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. Alzheimer's Disease Cooperative Study - PubMed (original) (raw)
Clinical Trial
Assessment of agitation in Alzheimer's disease: the agitated behavior in dementia scale. Alzheimer's Disease Cooperative Study
R G Logsdon et al. J Am Geriatr Soc. 1999 Nov.
Abstract
Objectives: To develop and evaluate the psychometric properties of a new measure of agitation, the Agitated Behavior in Dementia scale (ABID). The ABID consists of 16 items designed specifically to evaluate frequency of and caregiver reaction to common agitated behaviors in community-residing dementia patients.
Design: The ABID was administered at the baseline assessment of a multi-site controlled treatment study to reduce agitation in Alzheimer's Disease (AD). Reliability was assessed by evaluating internal consistency and test-retest correlations. Validity was assessed by examining correlations with other constructs, including demographics, cognitive status, and overall behavioral disturbance.
Setting: Twenty-one sites across the US, comprising the Alzheimer's Disease Cooperative Study, contributed subjects to the investigation.
Participants: A total of 148 community-residing AD patients, living with a spouse or adult relative who acted as an informant. Mean age was 75 years, and mean Mini-Mental State Exam (MMSE) score was 13.
Measurements: Cognitive status was assessed using the MMSE. Behavioral disturbance was assessed using the Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease, the Revised Memory and Behavior Problems Checklist, and the Cohen-Mansfield Agitation Inventory.
Results: Reliability of the ABID was excellent, with internal consistency of 0.70 and test-retest reliability of 0.60 to 0.73. Validity was confirmed by correlations with related measures and lack of correlation with unrelated constructs.
Conclusions: The ABID is brief, easy to administer, and provides objectively anchored observations of problems. It is a promising measure for studies of community-residing AD patients.
Similar articles
- Reliability and validity of the Japanese version of the Agitated Behaviour in Dementia Scale in Alzheimer's disease: three dimensions of agitated behaviour in dementia.
Torii K, Nakaaki S, Banno K, Murata Y, Sato J, Tatsumi H, Yamanaka K, Narumoto J, Mimura M, Akechi T, Furukawa TA. Torii K, et al. Psychogeriatrics. 2011 Dec;11(4):212-20. doi: 10.1111/j.1479-8301.2011.00371.x. Epub 2011 Oct 27. Psychogeriatrics. 2011. PMID: 22151240 - Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study.
Koss E, Weiner M, Ernesto C, Cohen-Mansfield J, Ferris SH, Grundman M, Schafer K, Sano M, Thal LJ, Thomas R, Whitehouse PJ. Koss E, et al. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S45-50. doi: 10.1097/00002093-199700112-00007. Alzheimer Dis Assoc Disord. 1997. PMID: 9236952 - Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].
Lin JS, O'Connor E, Rossom RC, Perdue LA, Burda BU, Thompson M, Eckstrom E. Lin JS, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. Report No.: 14-05198-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. Report No.: 14-05198-EF-1. PMID: 24354019 Free Books & Documents. Review. - Assessment of agitation.
Cohen-Mansfield J. Cohen-Mansfield J. Int Psychogeriatr. 1996 Summer;8(2):233-45. doi: 10.1017/s104161029600261x. Int Psychogeriatr. 1996. PMID: 8994894 Review.
Cited by
- Frequency of behavioral symptoms characterizes agitation in Alzheimer's disease.
Tractenberg RE, Gamst A, Weiner MF, Koss E, Thomas RG, Teri L, Thal L. Tractenberg RE, et al. Int J Geriatr Psychiatry. 2001 Sep;16(9):886-91. doi: 10.1002/gps.441. Int J Geriatr Psychiatry. 2001. PMID: 11571769 Free PMC article. - Usability and Acceptability of Social Robot Pets Among Community-Dwelling Veterans Living With Dementia and Their Caregivers.
Harris-Gersten ML, Davagnino JM, Alcorn ER, Hastings SN. Harris-Gersten ML, et al. Am J Alzheimers Dis Other Demen. 2023 Jan-Dec;38:15333175231200973. doi: 10.1177/15333175231200973. Am J Alzheimers Dis Other Demen. 2023. PMID: 37688378 Free PMC article. - A feasibility study and pilot randomised trial of a tailored prevention program to reduce falls in older people with mild dementia.
Wesson J, Clemson L, Brodaty H, Lord S, Taylor M, Gitlin L, Close J. Wesson J, et al. BMC Geriatr. 2013 Sep 3;13:89. doi: 10.1186/1471-2318-13-89. BMC Geriatr. 2013. PMID: 24004682 Free PMC article. Clinical Trial. - Detecting agitation and aggression in persons living with dementia: a systematic review of diagnostic accuracy.
Wong B, Wu P, Ismail Z, Watt J, Goodarzi Z. Wong B, et al. BMC Geriatr. 2024 Jun 26;24(1):559. doi: 10.1186/s12877-024-05143-6. BMC Geriatr. 2024. PMID: 38926638 Free PMC article. - Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?
Levy K, Lanctôt KL, Farber SB, Li A, Herrmann N. Levy K, et al. Drugs Aging. 2012 Mar 1;29(3):167-179. doi: 10.2165/11599140-000000000-00000. Drugs Aging. 2012. PMID: 22350526 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical